SPP1 and head and neck squamous cell carcinoma: Our study highlights the potential value of identifying and establishing therapeutic strategies targeting POSTN+ fibroblasts, SPP1+ macrophages, or the molecules involved in their crosstalk to inhibit HNSCC progression.